|
|
||||||||
2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men
1Department of Sports Medicine, Third Faculty of Medicine, Charles University, 2Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 3Obesity Research Unit, Institut National de la Santé et de la Recherche Médicale, Unité 586, and 4Department of Medical and Clinical Pharmacology, Faculty of Medicine, 31073 Toulouse, France
Submitted 14 November 2002 ; accepted in final form 21 May 2003
The aim of this study was to investigate whether hyperinsulinemia modifies
adrenergic control of lipolysis, with particular attention paid to the
involvement of antilipolytic
2-adrenergic receptors (AR).
Eight healthy male subjects (age: 23.9 ± 0.9 yr; body mass index: 23.8
± 1.9) were investigated during a 6-h euglycemichyperinsulinemic clamp
and in control conditions. Before and during the clamp, the effect of graded
perfusions of isoproterenol (0.1 and 1 µM) or epinephrine (1 and 10 µM)
on the extracellular glycerol concentration in subcutaneous abdominal adipose
tissue was evaluated by using the microdialysis method. Both isoproterenol and
epinephrine induced a dose-dependent increase in extracellular glycerol
concentration when infused for 60 min through the microdialysis probes before
and during hours 3 and 6 of the clamp. The
catecholamine-induced increase was significantly lower during the clamp than
before it, with the inhibition being more pronounced in hour 6 of the
clamp. Isoproterenol (1 µM)-induced lipolysis was reduced by 28 and 44%
during hours 3 and 6 of the clamp, respectively, whereas the
reduction of epinephrine (100 µM)-induced lipolysis was significantly
greater (by 63 and 70%, P < 0.01 and P < 0.04,
respectively) during the same time intervals. When epinephrine was infused in
combination with 100 µM phentolamine (a nonselective
-AR
antagonist), the inhibition of epinephrine (10 µM)-induced lipolysis was
only of 19 and 40% during hours 3 and 6 of the clamp,
respectively. The results demonstrate that, in situ, insulin counteracts the
epinephrine-induced lipolysis in adipose tissue. The effect involves
1) reduction of lipolysis stimulation mediated by the
-adrenergic pathway and 2) the antilipolytic component of
epinephrine action mediated by
2-ARs.
microdialysis; glycerol; isoproterenol; blood flow;
2-adrenergic receptor antagonist
This article has been cited by other articles:
![]() |
C. Moro, J. Galitzky, C. Sengenes, F. Crampes, M. Lafontan, and M. Berlan Functional and Pharmacological Characterization of the Natriuretic Peptide-Dependent Lipolytic Pathway in Human Fat Cells J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 984 - 992. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |